SREBF2 and colorectal carcinoma: Unlike normal enterocytes, which primarily rely on dietary feedback regulation, CRC cells activate SREBP2-driven biosynthesis to fuel malignant progression, thereby enhancing cell proliferation, invasion, and metabolic reprogramming (41, 131).